Target intelligence / Profile preview

Non-specific cellular components in skin

Molecular classification
Other
01

Overview

The term Non-specific cellular components in skin refers to the collective biological structures of the integumentary system, such as the stratum corneum, keratinocytes, and the lipid matrix, which are affected by drugs through non-molecular mechanisms (NCBI: Skin Barrier Function, 2022). These components primarily function as a protective barrier against environmental pathogens, UV radiation, and dehydration. In clinical pharmacology, this target is associated with topical agents that do not bind to specific receptors but instead alter the physical or chemical environment of the skin (StatPearls: Keratolytics, 2023). For example, keratolytics like salicylic acid work by dissolving the intercellular cement that holds keratinocytes together, while emollients like petrolatum create a physical barrier to prevent transepidermal water loss (DrugBank: Salicylic Acid, DB00906). This category is often used in pharmacological databases to describe the site of action for treatments of hyperkeratosis, xerosis, and various forms of dermatitis. Because it lacks a specific molecular identity, it is not considered a traditional therapeutic target for drug screening or precision medicine. Instead, it serves as a functional designation for drugs that provide symptomatic relief or structural modification to the skin surface.

Other names
Skin componentsEpidermal structuresDermal componentsStratum corneumSkin
02

Mechanism of action

Drugs targeting these components typically act through non-specific physical or chemical processes, such as keratolysis (dissolving the intercellular cement), occlusion (preventing transepidermal water loss), or caustic destruction of tissue (StatPearls: Keratolytics, 2023).

03

Biological functions

Barrier functionImmune responseOther
04

Disease associations

InflammationInfectionOther
05

Safety considerations

Skin irritationChemical burnsAllergic contact dermatitisSystemic toxicity from percutaneous absorption
06

Interacting drugs

Salicylic acid

6 more in the full profile.

Beyond the preview

Go deeper on Non-specific cellular components in skin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-specific cellular components in skin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call